Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2020 1
2021 3
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
EGFR-targeted fluorescence molecular imaging for intraoperative margin assessment in oral cancer patients: a phase II trial.
de Wit JG, Vonk J, Voskuil FJ, de Visscher SAHJ, Schepman KP, Hooghiemstra WTR, Linssen MD, Elias SG, Halmos GB, Plaat BEC, Doff JJ, Rosenthal EL, Robinson D, van der Vegt B, Nagengast WB, van Dam GM, Witjes MJH. de Wit JG, et al. Among authors: hooghiemstra wtr. Nat Commun. 2023 Aug 16;14(1):4952. doi: 10.1038/s41467-023-40324-8. Nat Commun. 2023. PMID: 37587149 Free PMC article. Clinical Trial.
Detection of Early Esophageal Neoplastic Barrett Lesions with Quantified Fluorescence Molecular Endoscopy Using Cetuximab-800CW.
Gabriëls RY, van Heijst LE, Hooghiemstra WTR, van der Waaij AM, Kats-Ugurlu G, Karrenbeld A, Robinson DJ, Tenditnaya A, Ntziachristos V, Gorpas D, Nagengast WB. Gabriëls RY, et al. Among authors: hooghiemstra wtr. J Nucl Med. 2023 May;64(5):803-808. doi: 10.2967/jnumed.122.264656. Epub 2023 Jan 5. J Nucl Med. 2023. PMID: 36604181
Multispectral optoacoustic tomography for in vivo detection of lymph node metastases in oral cancer patients using an EGFR-targeted contrast agent and intrinsic tissue contrast: A proof-of-concept study.
Vonk J, Kukačka J, Steinkamp PJ, de Wit JG, Voskuil FJ, Hooghiemstra WTR, Bader M, Jüstel D, Ntziachristos V, van Dam GM, Witjes MJH. Vonk J, et al. Among authors: hooghiemstra wtr. Photoacoustics. 2022 Apr 29;26:100362. doi: 10.1016/j.pacs.2022.100362. eCollection 2022 Jun. Photoacoustics. 2022. PMID: 35541024 Free PMC article.
Epidermal Growth Factor Receptor-Targeted Fluorescence Molecular Imaging for Postoperative Lymph Node Assessment in Patients with Oral Cancer.
Vonk J, de Wit JG, Voskuil FJ, Tang YH, Hooghiemstra WTR, Linssen MD, van den Broek E, Doff JJ, de Visscher SAHJ, Schepman KP, van der Vegt B, van Dam GM, Witjes MJH. Vonk J, et al. Among authors: hooghiemstra wtr. J Nucl Med. 2022 May;63(5):672-678. doi: 10.2967/jnumed.121.262530. Epub 2021 Sep 16. J Nucl Med. 2022. PMID: 34531264 Free PMC article. Clinical Trial.
Validation of Novel Molecular Imaging Targets Identified by Functional Genomic mRNA Profiling to Detect Dysplasia in Barrett's Esophagus.
Zhao X, Gabriëls RY, Hooghiemstra WTR, Koller M, Meersma GJ, Buist-Homan M, Visser L, Robinson DJ, Tenditnaya A, Gorpas D, Ntziachristos V, Karrenbeld A, Kats-Ugurlu G, Fehrmann RSN, Nagengast WB. Zhao X, et al. Among authors: hooghiemstra wtr. Cancers (Basel). 2022 May 17;14(10):2462. doi: 10.3390/cancers14102462. Cancers (Basel). 2022. PMID: 35626066 Free PMC article.
Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: A quantitative dose-escalation study.
Voskuil FJ, de Jongh SJ, Hooghiemstra WTR, Linssen MD, Steinkamp PJ, de Visscher SAHJ, Schepman KP, Elias SG, Meersma GJ, Jonker PKC, Doff JJ, Jorritsma-Smit A, Nagengast WB, van der Vegt B, Robinson DJ, van Dam GM, Witjes MJH. Voskuil FJ, et al. Among authors: hooghiemstra wtr. Theranostics. 2020 Mar 4;10(9):3994-4005. doi: 10.7150/thno.43227. eCollection 2020. Theranostics. 2020. PMID: 32226534 Free PMC article. Clinical Trial.
11 results